Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Neurology|February 28, 2007
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarkerRandall J Bateman, Guolin Wen, John C Morris, et al.
Neurology|May 26, 2004
The metabolic topography of posthypoxic myoclonusSteven J Frucht, Maja Trost, Yilong Ma, et al.
Neurology|April 23, 2003
The differential effect of PD and normal aging on early explicit sequence learningMaria-Felice Ghilardi, David Eidelberg, Giulia Silvestri, et al.
Neurology|January 7, 2021
Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of NeurodegenerationGanna Blazhenets, Lars Frings, Yilong Ma, et al.
Neurology|January 4, 2013
Metabolic changes in DYT11 myoclonus-dystoniaMaren Carbon, Deborah Raymond, Laurie Ozelius, et al.
Neurology|August 8, 2020
Association of education with Aβ burden in preclinical familial and sporadic Alzheimer diseaseJulie Gonneaud, Christophe Bedetti, Alexa Pichet Binette, et al.
Neurology|October 7, 2016
Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseasesPaul J Mattis, Martin Niethammer, Wataru Sako, et al.
Neurology|January 24, 2014
Abnormal metabolic network activity in REM sleep behavior disorderFlorian Holtbernd, Jean-François Gagnon, Ron B Postuma, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Pageof 3